Mutation Ensemble for Response to Programmed Cell Death 1 Inhibition in Thymic Carcinoma

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.03.027
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Letter: Programmed Cell Death Protein-1-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors

Frontiers in Oncology
Cancer ResearchOncology
2019English

Letter: Programmed Cell Death Protein-1-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma-Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

The Metastatic Dissemination of a Squamous Cell Carcinoma Arising From an Epidermal Cyst and Subsequent Failure to Respond to Programmed Death 1 Inhibition

JAAD Case Reports
Dermatology
2019English

Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Immunotherapy

JAMA Dermatology
DermatologyMedicine
2016English

Concordance Among Four Commercially Available, Validated Programmed Cell Death Ligand-1 Assays in Urothelial Carcinoma

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2019English

Complete and Sustained Response of Brain Metastases to Programmed Death 1 Antibody Monotherapy in Treatment-Naive Programmed Death Ligand 1–Positive Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Device Genetics for Programmed Cell Death

Journal of Japanese Society for Extremophiles
2008English

Indoleamine 2,3-Dioxygenase 1 and Programmed Cell Death-Ligand 1 Co-Expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy

Cancers
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy